Pharma

Your Article Summary

See Latest Articles

Cephalon Delivers Record Sales in the Second Quarter 2009
Cephalon, 08/05/09

Cephalon, Inc. reported second quarter 2009 sales of $539.0 million, an 11 percent increase compared to sales of $485.0 million for the second quarter 2008 and exceeding the company's sales guidance of $515 – $535 million. Basic income per common share for the quarter was $1.19. Excluding amortization expense and certain other items, basic adjusted income per common share for the quarter was $1.56, an increase of 25 percent over the comparable figure of $1.25 for the same period in 2008. Adjusted net income for the second quarter of 2009 was $110.7 million, a 31 percent increase over the comparable $84.5 million for the second quarter of 2008.

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

Abbott Declares 344th Consecutive Quarterly Dividend
Abbott, 12/15/09

Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering
Dendreon Coproration, 12/15/09

Pre-Budget Report response - GSK comments on patent box
GlaxoSmithKline, 12/11/09

 See all of Financial Reports